IFN-α cannot be used as a severity marker for COVID-19

The investigators found in a review article of 15 studies, that the plasma protein levels of type I IFN, based on peripheral measurement of IFN-α, do not demonstrate significant differences between mild, severe or critical patients. Therefore, IFN-α cannot be used alone as a severity marker for COVID-19.

Read more right here:
IFN-α cannot be used as a severity marker for COVID-19